ATE331716T1 - Nicht-nukleosidische inhibitoren der reverse transkriptase - Google Patents

Nicht-nukleosidische inhibitoren der reverse transkriptase

Info

Publication number
ATE331716T1
ATE331716T1 AT03816107T AT03816107T ATE331716T1 AT E331716 T1 ATE331716 T1 AT E331716T1 AT 03816107 T AT03816107 T AT 03816107T AT 03816107 T AT03816107 T AT 03816107T AT E331716 T1 ATE331716 T1 AT E331716T1
Authority
AT
Austria
Prior art keywords
sub
sup
alkyl
reverse transcriptase
cycloalkyl
Prior art date
Application number
AT03816107T
Other languages
English (en)
Inventor
Christiane Yoakim
Eric Malenfant
Bounkham Thavonekham
William W Ogilvie
Robert Deziel
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of ATE331716T1 publication Critical patent/ATE331716T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
AT03816107T 2002-09-19 2003-09-15 Nicht-nukleosidische inhibitoren der reverse transkriptase ATE331716T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41178502P 2002-09-19 2002-09-19

Publications (1)

Publication Number Publication Date
ATE331716T1 true ATE331716T1 (de) 2006-07-15

Family

ID=33097881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03816107T ATE331716T1 (de) 2002-09-19 2003-09-15 Nicht-nukleosidische inhibitoren der reverse transkriptase

Country Status (9)

Country Link
US (1) US7105510B2 (de)
EP (1) EP1554276B1 (de)
JP (1) JP4391426B2 (de)
AT (1) ATE331716T1 (de)
AU (1) AU2003303944A1 (de)
CA (1) CA2495721C (de)
DE (1) DE60306539T2 (de)
ES (1) ES2268499T3 (de)
WO (1) WO2004085437A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152625A1 (en) * 2002-12-16 2004-08-05 Boehringer Ingelheim International Gmbh Method for improving the pharmacokinetics of an NNRTI
GB0507695D0 (en) * 2005-04-15 2005-05-25 Novartis Ag Organic compounds
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
KR20100065191A (ko) 2007-09-14 2010-06-15 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 １,３-이치환된 ４-(아릴-ｘ-페닐)-１ｈ-피리딘-２-온
CA2696948C (en) 2007-09-14 2013-04-30 Jose Maria Cid-Nunez 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
KR20100080597A (ko) 2007-09-14 2010-07-09 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 １,３-이치환된-４-페닐-1ｈ-피리딘-2-온
EP2220083B1 (de) 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]-pyridin-derivate und ihre verwendung als positive allosterische modulatoren von mglur2-rezeptoren
CA2735764C (en) 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
AU2009304293B2 (en) 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
BRPI0921333A2 (pt) 2008-11-28 2015-12-29 Addex Pharmaceuticals Sa derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
NZ596078A (en) 2009-05-12 2013-06-28 Janssen Pharmaceuticals Inc 1,2,4-TRIAZOLO [4,3-a] PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OR PREVENTION OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
EA020671B1 (ru) 2009-05-12 2014-12-30 Янссен Фармасьютикалз, Инк. ПРОИЗВОДНЫЕ 1,2,4-ТРИАЗОЛО[4,3-a]ПИРИДИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2643320B1 (de) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridinderivate und ihre verwendung als positiv allosterische modulatoren des mglur2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR102414246B1 (ko) 2014-01-21 2022-06-27 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
LT3431106T (lt) 2014-01-21 2021-02-10 Janssen Pharmaceutica Nv Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
US6716836B2 (en) * 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) * 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
EP1554276B1 (de) 2006-06-28
WO2004085437A1 (en) 2004-10-07
DE60306539T2 (de) 2007-07-19
US20040106791A1 (en) 2004-06-03
ES2268499T3 (es) 2007-03-16
EP1554276A1 (de) 2005-07-20
CA2495721A1 (en) 2004-10-07
DE60306539D1 (de) 2006-08-10
CA2495721C (en) 2009-08-18
US7105510B2 (en) 2006-09-12
JP2006515312A (ja) 2006-05-25
JP4391426B2 (ja) 2009-12-24
AU2003303944A1 (en) 2004-10-18

Similar Documents

Publication Publication Date Title
DE60306539D1 (de) Nicht-nukleosidische inhibitoren der reverse transkriptase
ECSP045359A (es) Isoxazolinas 5 metiloximetil sustituidas por 3-heteroarilo utilizadas con herbicidas
BG101422A (bg) Бензоксазолни производни като бронхоразширяващи средства
JO2791B1 (en) Acid secretion inhibitor
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
UA19304A (uk) Фуhгіцидhий засіб
EA200401540A1 (ru) Спироиндолинпиперидиновые производные
BR0108303A (pt) Derivados do 1h-imidazopiridina
DE69104615D1 (de) Diphenylpiperazinderivat.
ATE353903T1 (de) Kristalline cefdinirsalze
DE60225019D1 (de) Nicht-nucleosidische inhibitoren der reverse transkriptase
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
EA200201255A1 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
DE60207104D1 (de) 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
NO20050871L (no) 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer
EA200500133A1 (ru) Производные пирролидина в качестве антагонистов окситоцина
CY1113031T1 (el) Παραγωγα ν-αμινοϊμιδαζολιου που αναστελουν ηιv
NO20033131L (no) Anvendelse av 2-amino-4-pyridylmetyl-tiazolinderivater som inhibitorer forinduktibel NO-syntase
WO2020003272A8 (en) An improved process for the preparation of venetoclax
DK1165485T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
EA200700179A1 (ru) Производные пиррола, их получение и их применение в терапии
EA200501556A1 (ru) Гетеробициклические соединения в качестве фунгицидов
ATE395063T1 (de) Pyridlsulfonamidopyrimidine zur behandlung von diabetischer nephropathie
DE60330381D1 (de) Zusammensetzung zur bekämpfung von arthropoden
EA200500138A1 (ru) Фунгицидные смеси на базе дитианона

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1554276

Country of ref document: EP